NH SPAC 2 - Asset Resilience Ratio
NH SPAC 2 (206640) has an Asset Resilience Ratio of 6.72% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 206640 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how NH SPAC 2's Asset Resilience Ratio has changed over time. See NH SPAC 2 (206640) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down NH SPAC 2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is NH SPAC 2 worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩18.44 Billion | 6.72% |
| Total Liquid Assets | ₩18.44 Billion | 6.72% |
Asset Resilience Insights
- Limited Liquidity: NH SPAC 2 maintains only 6.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NH SPAC 2 Industry Peers by Asset Resilience Ratio
Compare NH SPAC 2's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for NH SPAC 2 (2015–2024)
The table below shows the annual Asset Resilience Ratio data for NH SPAC 2.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 24.23% | ₩61.71 Billion ≈ $41.82 Million |
₩254.67 Billion ≈ $172.59 Million |
-9.20pp |
| 2023-12-31 | 33.43% | ₩76.20 Billion ≈ $51.64 Million |
₩227.90 Billion ≈ $154.45 Million |
+2.54pp |
| 2022-12-31 | 30.89% | ₩60.44 Billion ≈ $40.96 Million |
₩195.66 Billion ≈ $132.59 Million |
-4.72pp |
| 2021-12-31 | 35.61% | ₩68.45 Billion ≈ $46.39 Million |
₩192.24 Billion ≈ $130.28 Million |
-0.08pp |
| 2020-12-31 | 35.68% | ₩58.34 Billion ≈ $39.53 Million |
₩163.47 Billion ≈ $110.78 Million |
+14.27pp |
| 2019-12-31 | 21.42% | ₩21.69 Billion ≈ $14.70 Million |
₩101.26 Billion ≈ $68.62 Million |
-3.51pp |
| 2018-12-31 | 24.93% | ₩25.79 Billion ≈ $17.47 Million |
₩103.44 Billion ≈ $70.10 Million |
+1.63pp |
| 2017-12-31 | 23.30% | ₩25.20 Billion ≈ $17.08 Million |
₩108.17 Billion ≈ $73.30 Million |
+8.25pp |
| 2016-12-31 | 15.05% | ₩13.67 Billion ≈ $9.26 Million |
₩90.79 Billion ≈ $61.53 Million |
+5.49pp |
| 2015-12-31 | 9.56% | ₩6.86 Billion ≈ $4.65 Million |
₩71.71 Billion ≈ $48.59 Million |
-- |
About NH SPAC 2
Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testi… Read more